Clinical Trial Update: Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM [Phase 1, Phase 2]

View source ↗

Summary

An early-phase trial evaluating IP-001 following microwave ablation or irreversible electroporation for colorectal cancer with liver metastases. The study asses…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• IP-001 (IP-001)

Snippet

Sponsor: M.R. Meijerink | Conditions: Colorectal Cancer, Liver Metastases | Phase 1, Phase 2 | Status: RECRUITING